Phase I/IIa Clinical Trial of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigmented Epithelium (RPE, Opregen®) Transplantation in Advanced Dry Form Age-Related Macular Degeneration (AMD): Interim Results